KIT and cancer: Furthermore, transient expression of a c-kit-directed therapeutic may limit off-target toxicity in the bone marrow niche, and un-modified γδ T cells can provide additional cancer surveillance through interaction with stress antigens, which we have shown are up regulated on AML cells.